Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Circ Cardiovasc Interv. 2016 Jun;9(6):10.1161/CIRCINTERVENTIONS.115.003434 e003434. doi: 10.1161/CIRCINTERVENTIONS.115.003434

Table 3.

Angiographic Characteristics and Outcomes According to Retrograde Sequence

Variable Primary
retrograde
n = 248 (46%)
Retrograde after
antegrade failure
n =291 (54%)
p

Target Vessel
  RCA (%) 73.0 64.0 0.088
  LCX (%) 15.2 19.3
  LAD (%) 11.8 16.7
CTO length (mm)* 42.5 (30–70) 30.0 (20–50) <0.001
Interventional collaterals (%) 84.5 73.3 0.007
Proximal cap ambiguity (%) 58.3 38.1 <0.001
Moderate/severe tortuosity (%) 40.3 42.1 0.677
Moderate/severe calcification (%) 69.2 70.2 0.802
Poor distal target vessel (%) 56.8 47.8 0.069
In-stent restenosis (%) 12.8 14.0 0.681
Prior-failed CTO PCI (%) 25.6 16.1 0.007
J-CTO score* 3.3±0.9 2.9±1.1 <0.001
Collaterals used
  Septal (%) 57.3 53.3 0.353
  Epicardial (%) 34.7 30.6 0.312
  LIMA (%) 2.4 2.1 0.779
  SVG (%) 13.3 13.8 0.882
Collateral crossing
  Wire (%) 82.5 68.7 <0.001
    Sion (%) 65.3 71.5
    Fielder FC/XT (%) 17.8 19.5 0.179
    Other (%) 17.0 8.9
  Microcatheter (%) 78.7 66.9 0.004
    Corsair (%) 93.5 82.4
    Other (%) 6.5 17.6
  Externalization (%) 66.1 54.9 0.030
CTO wiring technique
  Reverse CART (%) 66.1 58.0
  Retrograde true lumen crossing
  (%)
17.8 20.4 0.313
  Retrograde wire as marker (%) 1.7 4.9
  CART (%) 1.7 3.7
  Guideliner rCART (%) 1.2 2.5
  Other/missing (%) 11.5 10.5
Procedure time (mins)* 170 (112 –236) 187 (142–234) 0.023
Contrast volume (ml)* 260 (200–375) 343 (250–440) <0.001
Patient air kerma radiation dose
(Gray)*
4.7 (2.5–6.2) 5.0 (3.2–6.9) 0.089
Technical success (%) 85.5 84.2 0.677
  Retrograde (%) 82.1 66.1
  Antegrade wire escalation (%) 6.1 11.0 <0.001
  Antegrade dissection/re-entry (%) 11.8 22.9
Procedural success (%)
MACE (%) 84.4 79.9 0.179
3.6 4.8 0.499

CART, controlled antegrade and retrograde tracking; CTO, chronic total occlusion; LAD, left anterior descending artery; LCX, left circumflex artery; LIMA, left internal mammary artery; MACE, major adverse cardiovascular events; MI, myocardial infarction; PCI, percutaneous coronary intervention; RCA, right coronary artery; SVG, saphenous vein graft.

*

mean±standard deviation or median (interquartile range).

Asahi Intecc, Nagoya, Japan,

Vascular Solutions, Minneapolis, MN